Park S H, Hann S K, Park Y K
Department of Dermatology, Yonsei University College of Medicine, Seoul, Korea.
Yonsei Med J. 1996 Dec;37(6):392-6. doi: 10.3349/ymj.1996.37.6.392.
Phototherapy with PUVA or UVB has been used to treat a wide variety of diseases such as psoriasis, vitiligo, atopic dermatitis and mycosis fungoides, etc. The present study was performed to investigate the pattern of phototherapy in the phototherapy clinic of Yonsei Medical Center. One thousand six hundred ninety two patients who received PUVA or UVB phototherapy were included in this study. We analyzed the protocols for phototherapy between 1985 and 1994. The number of phototherapy per year increased sharply until 1991 and thereafter it has remained relatively constant. The most common age group at the start of phototherapy was the third decade. The most common indications for PUVA and UVB phototherapy were vitiligo and psoriasis, respectively. Most patients had received less than 50 treatments of PUVA and less than 200 J/cm2 of cumulative UVA. Most patients had received less than 50 treatments with UVB and cumulative UVB doses were variable. We had not found any malignancy in the skin. Since the maximum safe cumulative doses of UVA or UVB have not yet been established, it is difficult to decide when phototherapy should be discontinued. The data presented in this study needs to be further analyzed in correlation with photoaging and cancer development for the safe usage of phototherapy.
补骨脂素加长波紫外线(PUVA)或中波紫外线(UVB)光疗已被用于治疗多种疾病,如银屑病、白癜风、特应性皮炎和蕈样肉芽肿等。本研究旨在调查延世大学医学院光疗诊所的光疗模式。本研究纳入了1692例接受PUVA或UVB光疗的患者。我们分析了1985年至1994年期间的光疗方案。每年的光疗次数在1991年之前急剧增加,此后一直保持相对稳定。光疗开始时最常见的年龄组是第三个十年。PUVA和UVB光疗最常见的适应症分别是白癜风和银屑病。大多数患者接受的PUVA治疗少于50次,累积UVA剂量少于200 J/cm²。大多数患者接受的UVB治疗少于50次,累积UVB剂量各不相同。我们在皮肤中未发现任何恶性肿瘤。由于尚未确定UVA或UVB的最大安全累积剂量,因此很难决定何时应停止光疗。为了光疗的安全使用,本研究中呈现的数据需要与光老化和癌症发展相关联进行进一步分析。